These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 7976857

  • 1. Evolution of cellular and humoral response against Tuberculin and antigen 85 complex during intravesical treatment with BCG of superficial bladder cancer.
    Zlotta A, Drowart A, van Vooren JP, Simon J, Schulman CC, Huygen K.
    Acta Urol Belg; 1994 Sep; 62(3):63-8. PubMed ID: 7976857
    [Abstract] [Full Text] [Related]

  • 2. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
    Zlotta AR, Drowart A, Van Vooren JP, de Cock M, Pirson M, Palfliet K, Jurion F, Vanonckelen A, Simon J, Schulman CC, Huygen K.
    J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341
    [Abstract] [Full Text] [Related]

  • 3. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
    Ratliff TL, Palmer JO, McGarr JA, Brown EJ.
    Cancer Res; 1987 Apr 01; 47(7):1762-6. PubMed ID: 3545453
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of action of intravesical BCG for bladder cancer.
    Ratliff TL.
    Prog Clin Biol Res; 1989 Apr 01; 310():107-22. PubMed ID: 2672010
    [Abstract] [Full Text] [Related]

  • 5. Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.
    Zlotta AR, Drowart A, Huygen K, De Bruyn J, Shekarsarai H, Decock M, Pirson M, Jurion F, Palfliet K, Denis O, Mascart F, Simon J, Schulman CC, Van Vooren JP.
    Clin Exp Immunol; 1997 Jul 01; 109(1):157-65. PubMed ID: 9218839
    [Abstract] [Full Text] [Related]

  • 6. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy.
    Chang SG, Lee SJ, Huh JS, Lee JH.
    Oncol Rep; 2001 Jul 01; 8(2):257-61. PubMed ID: 11182036
    [Abstract] [Full Text] [Related]

  • 7. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr 01; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 8. Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig.
    de Boer EC, Steerenberg PA, van der Meijden AP, van Klingeren B, de Jong WH, Debruyne FM, Ruitenberg EJ.
    Prog Clin Biol Res; 1992 Apr 01; 378():81-93. PubMed ID: 1301589
    [Abstract] [Full Text] [Related]

  • 9. The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer.
    Andrade PM, Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LC, Andrade E, Srougi M.
    Urol Oncol; 2010 Apr 01; 28(5):520-5. PubMed ID: 19272796
    [Abstract] [Full Text] [Related]

  • 10. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD, Lamm DL.
    Cancer Res; 1981 Jul 01; 41(7):2672-6. PubMed ID: 7018669
    [Abstract] [Full Text] [Related]

  • 11. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.
    de Reijke TM, de Boer EC, Kurth KH, Schamhart DH.
    J Urol; 1996 Feb 01; 155(2):477-82. PubMed ID: 8558640
    [Abstract] [Full Text] [Related]

  • 12. Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.
    van der Meijden AP, Steerenberg PA, van Hoogstraaten IM, Kerckhaert JA, Schreinemachers LM, Harthoorn-Lasthuizen EJ, Hagenaars AM, de Jong WH, Debruijne FM, Ruitenberg EJ.
    Cancer Immunol Immunother; 1989 Feb 01; 28(4):287-95. PubMed ID: 2784716
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y, Sawada Y, Inagaki T, Kohjimoto Y, Uekado Y, Shinka T.
    Int J Urol; 2007 Feb 01; 14(2):140-6. PubMed ID: 17302571
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.